Indeed, a number of cancers, including melanoma head and neck cancer, cutaneous squamous cell carcinoma, lung, kidney, and breast cancer, can pre-sent overexpression of the PD-1 ligand (PD-L1) by the tumor cells as a mechanism of immune evasion. Here, CD274 is linked to breast carcinoma.